Source link : https://newshealth.biz/health-news/compounders-face-deadline-to-stop-manufacturing-tirzepatide/
The Outsourcing Facilities Association (OFA), an organization representing bulk compounders, has appealed a Texas federal judge’s ruling that ended its ability to make copies of the dual glucagon-like peptide 1 (GLP-1) and glucose dependent insulinotropic polypeptide receptor agonist tirzepatide. Just last week, district court judge Mark Pittman declined to grant OFA’s request for an injunction […]
The post Compounders Face Deadline to Stop Manufacturing Tirzepatide first appeared on News Health.
Author : News Health
Publish date : 2025-03-12 10:06:00
Copyright for syndicated content belongs to the linked Source.
in Health